机译:2型糖尿病高血糖血症的个性化管理:糖尿病护理编辑专家论坛的思考
Diabetes Unit Department of Internal Medicine Hadassah Hebrew University Hospital Jerusalem;
Oregon Health and Science University Portland OR United States;
Dallas Diabetes and Endocrine Center Medical City and University of Texas Southwestern Medical;
University of North Carolina School of Medicine Chapel Hill NC United States;
Yale University School of Medicine Yale-New Haven Hospital New Haven CT United States;
Newcastle University Newcastle upon Tyne United Kingdom;
Department of Clinical and Experimental Medicine University of Pisa School of Medicine Pisa Italy;
Department of Internal Medicine University of Pisa School of Medicine Pisa Italy;
Department of Medicine and Therapeutics Chinese University of Hong Kong Prince of Wales Hospital;
Keenan Research Centre Departments of Medicine and Nutritional Sciences University of Toronto;
Mount Sinai Medical School New York NY United States Rambam Technion Hospital Haifa Israel;
University of Texas Health Science Center San Antonio TX United States;
Pennington Biomedical Research Center Louisiana State University System Baton Rouge LA United;
机译:2型糖尿病的高血糖的个性化管理:糖尿病护理编辑专家论坛的思考
机译:超越二甲双胍:在选择用于2型糖尿病治疗的第二种药物的决策过程中的安全考虑:糖尿病护理编辑专家论坛的反映
机译:2型糖尿病中的心血管结果试验:我们从这里去哪里? 来自糖尿病护理编辑专家论坛的思考
机译:个性化糖尿病管理中不同糖尿病类型的模型驱动分类
机译:糖尿病在精神疾病和2型糖尿病患者中患糖尿病护理的自我保健管理行为和障碍,与2型糖尿病的患者相比
机译:评论:Raz等。 2型糖尿病的高血糖的个性化管理:糖尿病护理编辑专家论坛的思考。糖尿病护理2013; 36:1779-1788
机译:2型糖尿病预防干预的真实翻译的更新和后续步骤:来自糖尿病护理编辑专家论坛的反思。 2016年糖尿病护理; 39:1186-1201